Alzheimer’s drug, the monoclonal antibody lecanemab, slowed decline in a phase 3 clinical trial, the company said.
admin, , HEALTH & FITNESS, 0
Related Articles
If you or someone you know is in crisis, these resources can help
If you are in crisis, or know someone who is, there are many resources that can help. These hotlines...
12 red states have refused Medicaid expansion. Biden’s funding offer may turn the tide.
An uninsured patient visited Dr. Gregory McCue’s practice in Cody, Wyoming, this week and explained that she can’t afford...
Johnson & Johnson’s $465 million opioid penalty overturned by Oklahoma court
The Oklahoma Supreme Court on Tuesday overturned a $465 million judgment against Johnson & Johnson in a lawsuit by the...
Ousted FDA vaccine chief says U.S. measles elimination status under threat as cases climb
Health Secretary Robert F. Kennedy Jr.’s “tepid endorsement” of measles vaccination puts the U.S. at risk of losing its...
The first mRNA flu shot is now available. Here’s who can get it.
The first mRNA flu shot is now available, but not everyone is eligible. Moderna’s mFlusiva is the first flu...
Tens of thousands of Johnson & Johnson Covid vaccine doses may go to waste
As demand for Covid-19 vaccines declines across the country, unused Johnson & Johnson vaccine doses are piling up on...
She got a job at Starbucks for access to IVF treatment. It cost more than her actual paycheck.
Leah Russell felt a surge of hope when she spotted Starbucks on a list of employers that offer fertility...
Chicago Public Schools cancels classes after union backs remote learning
CHICAGO — Classes in Chicago’s public schools will be canceled Wednesday after the teachers union voted to switch to...
